Covidien Reaches Into Past To Name Pharma Spin Off, Pulls Out Mallinckrodt
Nothing like a hurricane to catch up on some old news. At an investor day in early September, Covidien (COV) announced that the spinoff of its pharmaceutical group was on track for 2013 and would likely be completed by June of that year. The company also unveiled the new name for the company: Mallinckrodt Pharmaceuticals. The name choice… Read More »